Patent · US Active

Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumor

US11026914B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignee

Del Mar Pharmaceuticals (BC) Limited · CA

Inventors

Dennis M. Brown · Allentown, US
Kent C. Shih · Nashville, US
Anne Steino · Vancouver, CA
Richard Schwartz · Bethesda, US
Sarath Kanekal · San Diego, US
Howard A. Burris, III · Nashville, US
Jeffrey A. Bacha · Vancouver, CA
William J. Garner · Yardley, US
Shaun Fouse · Menlo Park, US

Key dates

Filing date	Apr 9, 2015
Grant date	Jun 8, 2021
Priority date	—
Expiry date	Apr 9, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods and compositions suitable for the treatment of malignancies such as recurrent glioma and progressive secondary brain tumor are disclosed. These methods employ a hexitol derivative such as dianhydrogalactitol, a derivative or analog of dianhydrogalactitol, diacetyldianhydrogalactitol, or a derivative or analog of diacetyldianhydrogalactitol. The compositions can include such hexitol derivatives.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.